Product Description
Etibo 250mg Tablet is used in the treatment of breast cancer. It works by stopping or slowing down the growth of cancer cells. It is either used alone or in combination with some other medicine to cure advanced-stage breast cancer.
-
What are Lapatinib Tablets IP?
- Lapatinib tablets contain the active ingredient lapatinib, which is a tyrosine kinase inhibitor. It works by blocking the action of certain proteins that are involved in the growth and spread of cancer cells.
-
What conditions are treated with Lapatinib Tablets IP?
- Lapatinib is used in the treatment of HER2-positive breast cancer, which is a type of breast cancer that overexpresses the HER2 protein. It is typically used in combination with other medications, such as capecitabine or letrozole, in patients who have not responded to other treatments.
-
How do I take Lapatinib Tablets IP?
- Lapatinib tablets are taken by mouth, usually once daily on an empty stomach, at least one hour before or one hour after a meal. The dosage and duration of treatment will depend on factors such as the stage and severity of the cancer and the patient's overall health. It's important to follow your doctor's instructions carefully.
-
What are the possible side effects of Lapatinib Tablets IP?
- Common side effects of lapatinib may include diarrhea, nausea, vomiting, fatigue, rash, and hand-foot syndrome (redness, swelling, and pain on the palms of the hands and soles of the feet). More serious side effects can occur, including liver problems, heart problems, and lung problems. It's essential to report any unusual symptoms to your doctor.
-
Can Lapatinib Tablets IP be used during pregnancy or breastfeeding?
- Lapatinib may harm an unborn baby if used during pregnancy and is not recommended for use during pregnancy. It is also not recommended for use while breastfeeding as it may pass into breast milk and harm the nursing infant. Women of childbearing potential should use effective contraception during treatment and for a period of time after discontinuing the medication.
-
Are there any medications that interact with Lapatinib Tablets IP?
- Lapatinib can interact with certain medications, including other chemotherapy drugs and medications that affect liver enzymes. It's crucial to inform your doctor about all medications you are taking, including prescription, over-the-counter, and herbal supplements, to avoid potentially harmful interactions.
-
How should Lapatinib Tablets IP be stored?
- Lapatinib tablets should be stored at room temperature away from light and moisture. Keep the medication out of reach of children and pets. Do not store in the bathroom. Check the expiration date and properly dispose of any expired medication.
-
Targeted Treatment for HER2-Positive Breast CancerLapatinib Tablets IP 250 mg provide a targeted oral therapy for adults with HER2-positive advanced or metastatic breast cancer. By inhibiting protein kinases, this medication disrupts the growth signals in cancer cells, offering a specialized approach when used alongside other treatments like Capecitabine.
Proper Storage and Handling of Lapatinib TabletsTo maintain potency and effectiveness, Lapatinib tablets should be stored below 30C, protected from moisture and direct light. The Alu-Alu blister packaging adds an extra layer of protection, ensuring a 24-month shelf life when stored as recommended.
FAQ's of Lapatinib Tablets IP:
Q: How should Lapatinib Tablets IP 250 mg be taken?
A: Lapatinib Tablets must be taken by mouth exactly as prescribed by your oncologist, usually in combination with other chemotherapeutic agents such as Capecitabine. Always swallow the tablets whole and do not crush or chew them.
Q: What is the primary benefit of using Lapatinib in breast cancer treatment?
A: Lapatinib offers targeted therapy against HER2-positive cancer cells, effectively slowing tumor growth and progression when used as a part of combination chemotherapy in advanced or metastatic breast cancer cases.
Q: When is Lapatinib prescribed, and for whom is it suitable?
A: Lapatinib is indicated for adults diagnosed with HER2-positive breast cancer that is advanced or metastatic, typically after other therapies. It is not suitable for pediatric or non-HER2-positive patients.
Q: Where should I store Lapatinib Tablets to ensure quality?
A: Store the tablets in their original Alu-Alu blisters at temperatures below 30C, away from moisture and direct sunlight, as improper storage can affect the medication's effectiveness.
Q: What precautions should be followed while using Lapatinib?
A: Lapatinib should only be used under strict medical supervision due to potential side effects and drug interactions. Inform your healthcare provider about all medications and supplements you are taking.
Q: What are the key ingredients in Lapatinib Tablets IP 250 mg?
A: Each tablet contains Lapatinib (as Lapatinib Ditosylate) as the active ingredient along with suitable pharmaceutical excipients necessary for tablet formulation.